The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Sodium 4-(((R)-1-(1-(4-(3,4-dihydroisoquinolin-2(1H)-yl)-4-oxobutyl)-1H-tetrazol-5-yl)-3,3-dimethylbutyl)amino)-3-hydroxybutanoate ID: ALA5188863
PubChem CID: 168281525
Max Phase: Preclinical
Molecular Formula: C24H35N6NaO4
Molecular Weight: 472.59
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)C[C@@H](NCC(O)CC(=O)[O-])c1nnnn1CCCC(=O)N1CCc2ccccc2C1.[Na+]
Standard InChI: InChI=1S/C24H36N6O4.Na/c1-24(2,3)14-20(25-15-19(31)13-22(33)34)23-26-27-28-30(23)11-6-9-21(32)29-12-10-17-7-4-5-8-18(17)16-29;/h4-5,7-8,19-20,25,31H,6,9-16H2,1-3H3,(H,33,34);/q;+1/p-1/t19?,20-;/m1./s1
Standard InChI Key: FCWGEYDEKGZDRT-TVEITMRYSA-M
Molfile:
RDKit 2D
35 36 0 0 0 0 0 0 0 0999 V2000
-4.3489 -0.7757 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
0.8200 2.4590 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1525 2.9438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4074 3.7285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2325 3.7285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4874 2.9438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6444 2.7302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8580 1.9332 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6550 1.7196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8685 0.9227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6656 0.7090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8791 -0.0879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6762 -0.3014 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.2957 -0.6713 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2850 0.3392 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8200 1.6337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 1.2212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 0.3961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2492 -0.0164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2492 -0.8416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9638 -1.2541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9638 -2.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2492 -2.4918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 -2.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 -1.2541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2494 -3.3205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9661 -3.7285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6762 -3.3164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6759 -2.4910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9638 0.3961 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2279 3.3137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0249 3.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6083 3.6836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6083 2.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8113 2.3031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 2 1 0
3 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
10 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
21 20 1 0
22 21 1 0
23 22 2 0
24 23 1 0
25 24 1 0
20 25 1 0
23 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
22 29 1 0
19 30 2 0
7 31 1 6
31 32 1 0
32 33 1 0
32 34 1 0
32 35 1 0
M CHG 2 1 1 13 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 472.59Molecular Weight (Monoisotopic): 472.2798AlogP: 1.94#Rotatable Bonds: 11Polar Surface Area: 133.47Molecular Species: ACIDHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.80CX Basic pKa: 7.74CX LogP: -0.87CX LogD: -1.00Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.45Np Likeness Score: -1.23
References 1. Ulgheri F, Spanu P, Deligia F, Loriga G, Fuggetta MP, de Haan I, Chandgudge A, Groves M, Domling A.. (2022) Design, synthesis and biological evaluation of 1,5-disubstituted α-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders., 229 [PMID:34823899 ] [10.1016/j.ejmech.2021.114002 ]